中信证券：医保新政出台，医疗器械迎来行业性投资机遇

Core Viewpoint - The new policy from the National Healthcare Security Administration (NHSA) aims to accelerate the promotion and adoption of surgical robots in China, which is expected to benefit the overall innovative medical device sector [1] Group 1: Surgical Robots and Related Services - The NHSA has released guidelines for pricing related to surgical robots and surgical consumables, indicating a structured approach to support the industry [1] - The guidelines are expected to expand continuously in the future, which will further benefit innovative medical device products [1] Group 2: Investment Opportunities - Investors are encouraged to focus on the medical industry chain, particularly in the surgical robot sector and its upstream and downstream industries, including laparoscopic robots, orthopedic robots, and neurosurgical robots [1] - There is a recommendation to pay attention to high-value consumables in minimally invasive surgery, orthopedics, gastroenterology, cardiovascular, and neurology [1]